120 related articles for article (PubMed ID: 21639680)
1. Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin.
Weindl G; Castello F; Schäfer-Korting M
Altern Lab Anim; 2011 May; 39(2):173-87. PubMed ID: 21639680
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid therapy-induced skin atrophy.
Schoepe S; Schäcke H; May E; Asadullah K
Exp Dermatol; 2006 Jun; 15(6):406-20. PubMed ID: 16689857
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model.
Zöller NN; Kippenberger S; Thaçi D; Mewes K; Spiegel M; Sättler A; Schultz M; Bereiter-Hahn J; Kaufmann R; Bernd A
Toxicol In Vitro; 2008 Apr; 22(3):747-59. PubMed ID: 18249522
[TBL] [Abstract][Full Text] [Related]
5. Suppression of hyaluronan synthase 2 expression reflects the atrophogenic potential of glucocorticoids.
Averbeck M; Gebhardt C; Anderegg U; Simon JC
Exp Dermatol; 2010 Aug; 19(8):757-9. PubMed ID: 20659158
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.
Lange K; Kleuser B; Gysler A; Bader M; Maia C; Scheidereit C; Korting HC; Schäfer-Korting M
Skin Pharmacol Appl Skin Physiol; 2000; 13(2):93-103. PubMed ID: 10754457
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
8. Shortened treatment duration of glucocorticoid-induced skin atrophy in rats.
Schoepe S; Vonk R; Schäcke H; Zollner TM; Asadullah K; Röse L
Exp Dermatol; 2011 Oct; 20(10):853-5. PubMed ID: 21824195
[TBL] [Abstract][Full Text] [Related]
9. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
Lange K; Gysler A; Bader M; Kleuser B; Korting HC; Schäfer-Korting M
Pharm Res; 1997 Dec; 14(12):1744-9. PubMed ID: 9453063
[TBL] [Abstract][Full Text] [Related]
10. Skin Anti-Inflammatory Potential with Reduced Side Effects of Novel Glucocorticoid Receptor Agonists.
Flori E; Mosca S; Kovacs D; Briganti S; Ottaviani M; Mastrofrancesco A; Truglio M; Picardo M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203435
[TBL] [Abstract][Full Text] [Related]
11. Effect of RU 486 on the atrophogenic and antiinflammatory effects of glucocorticoids in skin.
Iwasaki K; Mishima E; Miura M; Sakai N; Shimao S
J Dermatol Sci; 1995 Sep; 10(2):151-8. PubMed ID: 8534614
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor blockade improves glucocorticoid-induced skin atrophy but partially ameliorates anti-inflammatory actions in an irritative model in human skin explants.
Boix J; Nguyen VT; Farman N; Aractingi S; Pérez P
Exp Dermatol; 2018 Feb; 27(2):185-187. PubMed ID: 29178328
[TBL] [Abstract][Full Text] [Related]
13. Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro.
Wach F; Bosserhoff A; Kurzidym U; Nowok K; Landthaler M; Hein R
Skin Pharmacol Appl Skin Physiol; 1998; 11(1):43-51. PubMed ID: 9603668
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFalpha in human epidermal keratinocytes (HaCaT).
Onda K; Nagashima M; Kawakubo Y; Inoue S; Hirano T; Oka K
Biochem Biophys Res Commun; 2006 Dec; 351(1):266-72. PubMed ID: 17054908
[TBL] [Abstract][Full Text] [Related]
15. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
[TBL] [Abstract][Full Text] [Related]
16. Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.
Røpke MA; Alonso C; Jung S; Norsgaard H; Richter C; Darvin ME; Litman T; Vogt A; Lademann J; Blume-Peytavi U; Kottner J
J Dermatol Sci; 2017 Dec; 88(3):330-338. PubMed ID: 28911799
[TBL] [Abstract][Full Text] [Related]
17. Artocarpus altilis heartwood extract protects skin against UVB in vitro and in vivo.
Tiraravesit N; Yakaew S; Rukchay R; Luangbudnark W; Viennet C; Humbert P; Viyoch J
J Ethnopharmacol; 2015 Dec; 175():153-62. PubMed ID: 26387741
[TBL] [Abstract][Full Text] [Related]
18. In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin.
Jung S; Lademann J; Darvin ME; Richter C; Pedersen CB; Richter H; Schanzer S; Kottner J; Blume-Peytavi U; Røpke MA
J Biomed Opt; 2017 Jul; 22(7):76018. PubMed ID: 28753693
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts.
Korting HC; Hülsebus E; Kerscher M; Greber R; Schäfer-Korting M
Br J Dermatol; 1995 Jul; 133(1):54-9. PubMed ID: 7669640
[TBL] [Abstract][Full Text] [Related]
20. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
Kerscher MJ; Hart H; Korting HC; Stalleicken D
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
